Tempus AI: A Good Bet For The Future Of Health Care [Seeking Alpha]
Tempus AI, Inc. - Class A (TEM)
Company Research
Source: Seeking Alpha
TEM's Genomics segment drives strong revenue growth, with oncology and hereditary testing volumes rising significantly year-over-year. Gross margin expansion, narrowing losses, and a solid cash position highlight TEM's improving profitability and financial health. Valuation contraction presents an attractive buying opportunity, as TEM's unique position at the intersection of AI and healthcare supports a strong growth outlook. J Studios/DigitalVision via Getty Images As stated in my previous article on Tempus AI, Inc. (NASDAQ: TEM ), the medical field is one of the most exciting areas to apply artificial intelligence. For those that are suffering from currently untreatable This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensati
Show less
Read more
Impact Snapshot
Event Time:
TEM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TEM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TEM alerts
High impacting Tempus AI, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
TEM
News
- Tempus AI, Inc. (TEM): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- Tempus AI (NASDAQ:TEM) was given a new $85.00 price target on by analysts at Morgan Stanley.MarketBeat
- Cathie Wood's Health Tech Bet: Why Analysts See Long-Term Upside in Tempus AI (TEM) [Yahoo! Finance]Yahoo! Finance
- Tempus AI (NASDAQ:TEM) had its "buy" rating reaffirmed by analysts at BTIG Research.MarketBeat
- Tempus to Participate in the Piper Sandler 37th Annual Healthcare ConferenceBusiness Wire
TEM
Earnings
- 11/4/25 - Beat
TEM
Sec Filings
- 12/5/25 - Form 144
- 12/3/25 - Form 4
- 12/3/25 - Form 4
- TEM's page on the SEC website